Official UK procurement notice
Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
Authority: London School of Hygiene & Tropical Medicine (Education)
What is being bought
Published requirement descriptionManufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
CPV: Antihaemorrhagics · Cartons · Clinical products · Glass ampoules · Medical needles · Medicinal products for the blood and blood-forming organs · Packaging and related services · Pharmaceutical products · Syringes
The lotProcurement structure
single lot · value publishedLot #1Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023AwardedPublished value£975,000
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Technical: 70%
- price: 30%
Published award criteria (2)
- Technical: 70
- Price: 30
- Suitability
GMP and MHRA certification
- Price carries 30 of 100 points: a 10% discount moves about 3 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 22 Nov 2021, 18:10 GMT
- Last source update
- 21 Aug 2023, 15:21 BST
- Award evaluation window
- 5 Jan 2022 – …
- Authority reference
LSHTM-2021-29- FTS notice number
2023/S 000-024521- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02f911Find a Tender
How it was run
Official notice- Submission deadline
- 5 Jan 2022, 13:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bids opened
- 5 Jan 2022, 13:00 GMT
Timeline
5 Jan 2022 → 21 Aug 2023 · 4 dates- Submission deadline5 Jan 2022, 13:00 GMT
- Bids opened5 Jan 2022, 13:00 GMT
- Bids must remain valid until5 Apr 2022, 23:59 BST
- Notice published21 Aug 2023, 15:21 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete21 Aug 2023, 15:21 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Sharp Clinical Services (UK) Ltd | £1,066,444 † | — | Awarded |
Contracts
Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial · Sharp Clinical Services (UK) Ltd
- Signed
- 10 Aug 2023
- Value
- £1,066,444
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The Royal Courts of JusticeReview body
Bidders & participating suppliers
1 commercial party on the notice- Sharp Clinical Services (UK) LtdAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria